Valuation: Certara, Inc.

Market Cap 1.23B 1.07B 996M 910M 1.72B 117B 1.74B 11.68B 4.58B 58.73B 4.62B 4.52B 196B P/E 2026 *
-39.1x
P/E 2027 * 861x
Enterprise Value 1.29B 1.11B 1.04B 952M 1.79B 123B 1.82B 12.21B 4.79B 61.4B 4.83B 4.73B 204B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 3.09x
Free-Float
67.06%
Yield 2026 *
-
Yield 2027 * -
1 day-1.59%
1 week-1.34%
Current month-0.37%
1 month+19.20%
3 months+27.89%
6 months+15.29%
Current year-8.40%
1 week 7.9
Extreme 7.895
8.28
1 month 6.33
Extreme 6.332
8.39
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
11/05/26 Issuer sale

Executive/Senior Manager

-599,657 0.3911%
01/04/26 Fiscal year

Head of Human Resources

22,590 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.59%-1.34%-26.23%-51.24% 1.23B
+1.21%+3.78%-3.06%+56.71% 3,758B
+1.87%+39.46%-6.27%+1,037.12% 421B
+11.48%-4.69%+99.21%+187.46% 93.64B
-2.16%-1.26%-5.72%+47.12% 91.41B
-1.04%+5.00%-33.54%-4.57% 78.83B
+1.21%+3.28%-22.23%+100.49% 70.31B
+2.87%+3.43%+16.65%+83.14% 47.41B
+1.88%+46.44%-9.63%-23.09% 38.54B
+3.64%+27.20%+153.43%+312.78% 38.4B
Average +1.25%+236.72%+16.26%+174.59% 463.86B
Weighted average by Cap. -0.09%+443.55%-0.71%+149.48%

Financials

2026 *2027 *
Net sales 379M 328M 306M 280M 528M 36.11B 536M 3.59B 1.41B 18.06B 1.42B 1.39B 60.16B 391M 339M 317M 290M 546M 37.34B 554M 3.71B 1.46B 18.68B 1.47B 1.44B 62.21B
Net income -30.56M -26.46M -24.73M -22.6M -42.59M -2.91B -43.26M -290M -114M -1.46B -115M -112M -4.86B 3.62M 3.13M 2.93M 2.68M 5.04M 345M 5.12M 34.33M 13.47M 173M 13.58M 13.29M 575M
Net Debt 55.8M 48.31M 45.15M 41.27M 77.77M 5.32B 78.98M 530M 208M 2.66B 210M 205M 8.87B -23.11M -20.01M -18.7M -17.09M -32.21M -2.2B -32.72M -219M -86.06M -1.1B -86.79M -84.9M -3.67B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
10/08/26 $8.070 -1.59% 3,057,088
07/08/26 $8.200 +0.86% 2,227,086
06/08/26 $8.130 +1.50% 5,787,548
05/08/26 $8.010 +2.69% 3,410,090
04/08/26 $7.800 -4.65% 10,801,617
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
8.070USD
Average target price
8.040USD
Spread / Average Target
-0.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock